Sergey Moiseev

6.4k total citations
200 papers, 1.0k citations indexed

About

Sergey Moiseev is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Nephrology. According to data from OpenAlex, Sergey Moiseev has authored 200 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 52 papers in Rheumatology and 44 papers in Nephrology. Recurrent topics in Sergey Moiseev's work include Vasculitis and related conditions (44 papers), Renal Diseases and Glomerulopathies (28 papers) and Lysosomal Storage Disorders Research (21 papers). Sergey Moiseev is often cited by papers focused on Vasculitis and related conditions (44 papers), Renal Diseases and Glomerulopathies (28 papers) and Lysosomal Storage Disorders Research (21 papers). Sergey Moiseev collaborates with scholars based in Russia, Tajikistan and United Kingdom. Sergey Moiseev's co-authors include Pavel Novikov, David Jayne, Н А Мухин, В. В. Фомин, N. Bulanov, Natalia Chebotareva, Yoshikazu Inoue, Kevin K. Brown, Masataka Kuwana and Toby M. Maher and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sergey Moiseev

141 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergey Moiseev Russia 17 407 242 240 239 216 200 1.0k
Jean‐François Augusto France 21 375 0.9× 281 1.2× 86 0.4× 235 1.0× 269 1.2× 86 1.3k
Yoko Obata Japan 18 139 0.3× 334 1.4× 89 0.4× 95 0.4× 242 1.1× 78 996
George M. Nassar United States 19 568 1.4× 637 2.6× 111 0.5× 83 0.3× 154 0.7× 48 1.6k
Gianpaola Monti Italy 16 1.2k 2.9× 226 0.9× 136 0.6× 113 0.5× 209 1.0× 37 1.7k
Ji Seon Oh South Korea 17 193 0.5× 182 0.8× 81 0.3× 403 1.7× 248 1.1× 119 1.0k
Eleanor L. Ramos United States 21 400 1.0× 293 1.2× 55 0.2× 225 0.9× 134 0.6× 43 2.5k
Hernán Trimarchi Argentina 23 238 0.6× 1.1k 4.4× 201 0.8× 153 0.6× 165 0.8× 115 1.7k
Benjamin Seeliger Germany 19 451 1.1× 53 0.2× 232 1.0× 96 0.4× 236 1.1× 66 1.2k
E. Bertoni Italy 21 218 0.5× 187 0.8× 58 0.2× 129 0.5× 125 0.6× 94 1.4k
Khalil El Karoui France 21 201 0.5× 796 3.3× 66 0.3× 221 0.9× 328 1.5× 58 1.6k

Countries citing papers authored by Sergey Moiseev

Since Specialization
Citations

This map shows the geographic impact of Sergey Moiseev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Moiseev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Moiseev more than expected).

Fields of papers citing papers by Sergey Moiseev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Moiseev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Moiseev. The network helps show where Sergey Moiseev may publish in the future.

Co-authorship network of co-authors of Sergey Moiseev

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Moiseev. A scholar is included among the top collaborators of Sergey Moiseev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Moiseev. Sergey Moiseev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Rohit, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, et al.. (2025). Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatology and Therapy. 12(5). 855–871.
2.
Moiseev, Sergey, et al.. (2024). Alpha-mannosidosis: a diagnostic journey in patients with ultra-rare disease. 33(1). 67–72. 1 indexed citations
4.
Moiseev, Sergey, et al.. (2024). Kidney involvement in rare hereditary diseases. Terapevticheskii arkhiv. 96(6). 559–564.
5.
Strizhakov, Leonid A., et al.. (2023). Rheumatoid factor: study history and concept evolution. Terapevticheskii arkhiv. 95(5). 444–446. 1 indexed citations
7.
Brovko, Michail, et al.. (2023). Interstitial pneumonia with autoimmune features: monocentric prospective study. Terapevticheskii arkhiv. 95(3). 224–229. 1 indexed citations
8.
Bulanov, N., et al.. (2023). Damage to extracranial arteries in giant cell arteritis according to PET/CT. SHILAP Revista de lepidopterología. 61(1). 106–111. 2 indexed citations
9.
Ponomareva, Liubov A., et al.. (2023). Lung involvement in rheumatoid arthritis. SHILAP Revista de lepidopterología. 17(2). 77–81.
10.
Ponomareva, Liubov A., et al.. (2022). Interstitial lung disease associated with systemic sclerosis in a patient with long-term employment as a marble worker. SHILAP Revista de lepidopterología. 16(4). 63–68.
11.
Brovko, Michail, et al.. (2022). Organizing pneumonia as a pulmonary manifestation of post-COVID syndrome: features of diagnosis and treatment. Terapevticheskii arkhiv. 94(4). 497–502. 1 indexed citations
12.
Strizhakov, Leonid A., et al.. (2021). The state of cytokine regulation and endothelial dysfunction in the combined course of vibration disease and arterial hypertension. Terapevticheskii arkhiv. 93(6). 693–698. 5 indexed citations
13.
Chebotareva, Natalia, et al.. (2021). Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients. Kidney Research and Clinical Practice. 40(2). 241–249. 9 indexed citations
14.
Brovko, Michail, et al.. (2020). Visceral leishmaniasis: a challenging diagnosis in internal medicine. SHILAP Revista de lepidopterología. 92(11). 117–121. 1 indexed citations
15.
Strizhakov, Leonid A., et al.. (2020). Immunological features and prognosis in modern forms of occupational lung diseases. Russian Journal of Occupational Health and Industrial Ecology. 81–88. 3 indexed citations
16.
Moiseev, Sergey, Jiwon M. Lee, N. Bulanov, et al.. (2020). The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis. Clinical & Experimental Immunology. 202(3). 394–402. 42 indexed citations
17.
Drelichman, Guillermo, Gilberto Castañeda‐Hernández, Muhlis Cem Ar, et al.. (2019). The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease. American Journal of Hematology. 95(3). 233–237. 9 indexed citations
18.
Попова, Е. Н., Leonid A. Strizhakov, Sergey Moiseev, et al.. (2018). Clinical features of cardiac lesion in patients with generalized sarcoidosis. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Moiseev, Sergey. (2016). THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Мухин, Н А, et al.. (2004). Cardiorenai interactions: ciinicai indications and roie in pathogenesis of cardiovascular and renal diseases. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026